🇮🇳 India Stock Screener ← Switch market ★ Elite Club ⚡ StockGenie AI

INVENTURUS KNOWLEDGE SO L IKS NIFTY_SMALLNSEPHARMA

Healthcare · Health Information Services · India
https://ikshealth.com

Inventurus Knowledge Solutions Limited operates as a technology-enabled healthcare solutions provider. The company offers a care enablement platform that assists physician businesses in outpatient and inpatient care activities in the United States, Canada, and Australia. The company offers a platform that serves healthcare organizations, including health systems/ integrated delivery networks, academic medical centers, multi-specialty medical groups, single-specialty medical groups, ancillary healthcare organizations, and other outpatient healthcare delivery organizations. Inventurus Knowledge Solutions Limited was incorporated in 2006 and is based in Navi Mumbai, India.

READ MORE ›
₹1,675.60
+11.69% 1Y

Market & Price

Market Cap
₹28,085.96 Cr
Current Price
₹1,675.60
High / Low (52W)
₹1,855.70 / ₹1,274.90
Beta
-

Valuation

Stock P/E
39.68
Industry PE
37.60
Forward P/E
27.48
PEG Ratio
-
Book Value
₹167.36
Price to Book
10.01
P/S
8.79
EV/EBITDA
25.82
Dividend Yield
-

Profitability & Returns

ROCE
29.57%
ROE
31.44%
ROA
16.52%
Profit Margin
22.59%
Op Margin
35.14%
EPS (Latest Qtr)
₹12.06
EPS (TTM)
₹42.23

Balance Sheet & Liquidity

Debt/Equity
0.27
Quick Ratio
1.21
Current Ratio
1.35
Debt
₹752.52 Cr
Total Assets
₹4,267.88 Cr
Current Assets
₹1,309.64 Cr
Working Capital
₹339.59 Cr

Ownership

Promoter Holding
73.40%
Chg in Prom Hold
-
FII / Inst Holding
8.81%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
₹28,179.30 Cr
Total Revenue (TTM)
₹3,193.79 Cr
EBITDA
₹1,091.34 Cr
Free Cash Flow
₹881.10 Cr
Operating Cash Flow
₹673.59 Cr
Shares Outstanding
₹16.76 Cr
Gross Margin
49.01%
Payout Ratio
0.00%

Growth (CAGR)

Revenue 5Y
45.76%
Profit 5Y
33.21%
Revenue (YoY)
18.50%
Earnings (YoY)
38.60%

PROS

  • Strong return on equity of 31.4%.
  • Healthy ROCE of 29.6%.
  • Excellent profit margin of 22.6%.
  • Compounding revenue at 45.8% over 5 years.
  • Profit CAGR of 33.2% over 5 years.
  • Generates positive free cash flow.

CONS

  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

Price Chart

NSE TradingView Screener.in

Fundamental Growth

Figures from the latest reported periods. CAGR is computed across the displayed window (quarterly CAGR is annualised assuming 4 quarters per year).

Peer comparison

Peer companies in the same sector (Healthcare).

#NameCMP ₹P/E Mkt CapDiv Yld % ROCE %ROE % Rev CAGR 5Y %Profit CAGR 5Y %
1 IKS INVENTURUS KNOWLEDGE SO L NIFTY_SMALLNSEPHARMA 1,675.60 39.68 ₹28,085.96 Cr - 29.57% 31.44% 45.76% 33.21%
2 SUNPHARMA Sun Pharmaceutical Industries Limited NIFTY50NSEAIPHARMA 1,799.20 37.59 ₹4.32 L Cr 0.92% 17.94% 14.72% 10.39% 10.65%
3 DIVISLAB Divi's Laboratories Limited NSEPHARMA 6,667.00 68.97 ₹1.77 L Cr 0.45% 18.96% 16.19% 11.27% 12.08%
4 TORNTPHARM Torrent Pharmaceuticals Limited NSEPHARMA 4,410.80 68.96 ₹1.49 L Cr 0.86% 9.06% 16.98% 13.27% 20.21%
5 CIPLA Cipla Limited NIFTY50NSEAIPHARMA 1,401.00 29.16 ₹1.13 L Cr 0.93% 14.88% 11.74% 7.23% 11.45%
6 DRREDDY Dr. Reddy's Laboratories Limited NIFTY50NSEAIPHARMA 1,303.50 25.90 ₹1.09 L Cr 0.61% 14.00% 11.83% 10.96% -2.35%
7 ZYDUSLIFE Zydus Lifesciences Limited NSEPHARMA 1,077.70 21.51 ₹1.08 L Cr 0.09% 19.24% 18.32% 16.55% 36.99%
8 LUPIN Lupin Limited NIFTY_MIDNSEPHARMA 2,267.70 19.49 ₹1.04 L Cr 0.53% 28.42% 26.91% 19.10% 131.46%
9 MANKIND Mankind Pharma Limited NIFTY_MIDNSEPHARMA 2,375.60 51.29 ₹98,090.71 Cr 0.08% 13.78% 12.45% 17.73% 14.28%
⚙Ad space

Quarterly Results

Figures in INR.

Metric Dec 2024Mar 2025Jun 2025Dec 2025Mar 2026
Revenue 657.16 Cr723.96 Cr740.10 Cr814.95 Cr857.65 Cr
Cost of Revenue 383.37 Cr386.55 Cr395.96 Cr405.91 Cr419.75 Cr
Gross Profit 273.79 Cr337.41 Cr344.13 Cr409.04 Cr437.90 Cr
Operating Expenses 120.08 Cr139.56 Cr134.28 Cr159.49 Cr171.73 Cr
Operating Income 153.71 Cr197.84 Cr209.85 Cr249.56 Cr266.17 Cr
EBITDA 208.45 Cr229.44 Cr240.86 Cr284.76 Cr299.69 Cr
Interest Expense 20.54 Cr21.02 Cr18.08 Cr23.34 Cr12.68 Cr
Pretax Income 160.16 Cr180.09 Cr194.88 Cr229.37 Cr252.96 Cr
Tax Provision 30.48 Cr32.28 Cr43.34 Cr46.04 Cr46.99 Cr
Net Income 129.68 Cr147.80 Cr151.54 Cr183.33 Cr205.97 Cr
Diluted EPS 7.608.708.8510.7312.06

Profit & Loss (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue -1,031.30 Cr1,816.91 Cr2,663.99 Cr3,193.79 Cr
Cost of Revenue -509.31 Cr974.79 Cr1,495.35 Cr1,628.67 Cr
Gross Profit -521.99 Cr842.12 Cr1,168.64 Cr1,565.11 Cr
Operating Expenses -151.37 Cr376.05 Cr511.59 Cr597.92 Cr
Operating Income -370.62 Cr466.07 Cr657.05 Cr967.19 Cr
EBITDA -389.26 Cr559.16 Cr808.71 Cr1,099.31 Cr
Interest Expense -5.36 Cr58.94 Cr89.77 Cr70.25 Cr
Pretax Income -359.34 Cr441.67 Cr606.28 Cr904.91 Cr
Tax Provision -54.12 Cr71.18 Cr120.22 Cr183.36 Cr
Net Income -305.23 Cr370.49 Cr486.06 Cr721.55 Cr
Diluted EPS -17.7921.5928.6242.26

Compounded Sales Growth

5 Years:45.76%
1 Year:18.50%

Compounded Profit Growth

5 Years:33.21%
1 Year:38.60%

Stock Price Performance

1 Year:+11.69%
6 Months:+6.86%
3 Months:+8.79%
1 Month:+7.56%

Balance Sheet (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Total Assets -988.31 Cr3,027.52 Cr3,051.84 Cr4,267.88 Cr
Current Assets -698.19 Cr897.79 Cr783.87 Cr1,309.64 Cr
Cash & Equivalents -123.62 Cr143.81 Cr180.42 Cr388.72 Cr
Inventory -074.70 L05.80 L
Receivables -154.96 Cr353.94 Cr450.03 Cr564.48 Cr
Total Liabilities -159.67 Cr1,869.66 Cr1,262.14 Cr1,467.64 Cr
Current Liabilities -114.94 Cr790.02 Cr521.18 Cr970.05 Cr
Long Term Debt -0812.33 Cr509.27 Cr274.99 Cr
Total Debt -52.35 Cr1,311.09 Cr855.62 Cr752.51 Cr
Total Equity -828.64 Cr1,157.86 Cr1,789.69 Cr2,800.24 Cr
Shares Outstanding -16.67 Cr16.67 Cr17.16 Cr17.16 Cr

Cash Flows (Annual)

Figures in INR.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow -287.98 Cr209.77 Cr317.89 Cr673.59 Cr
Investing Cash Flow --155.96 Cr-1,141.28 Cr244.45 Cr-210.00 Cr
Financing Cash Flow --152.19 Cr780.37 Cr-389.49 Cr-411.80 Cr
Capital Expenditure --8.55 Cr-32.71 Cr-42.38 Cr-60.64 Cr
Free Cash Flow -279.43 Cr177.06 Cr275.51 Cr612.95 Cr
Net Change in Cash --20.17 Cr-151.14 Cr172.85 Cr51.78 Cr

Ratios (Annual)

Figures in %.

Metric Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Gross Margin % -50.6%46.3%43.9%49.0%
Operating Margin % -35.9%25.7%24.7%30.3%
Net Margin % -29.6%20.4%18.2%22.6%
ROE % -36.8%32.0%27.2%25.8%
ROCE % -42.4%20.8%26.0%29.3%

Shareholding Pattern

Insiders
73.40%
Institutions
8.81%
Public Float
33.11%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for IKS

No recent headlines available.

Explore More

📊 Healthcare Sector 🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All India Stocks
⚙Ad space